Testing Gene PilotLX for Latinx cancer patients
Part of Cancer clinical trials.
This trial is testing a new way to use genetic testing (Gene PilotLX) for Latinx patients with solid tumor cancers. It aims to see if this approach can help personalize cancer care for the Latinx community.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as Latinx (Hispanic or Latino)
- You have been diagnosed with a solid tumor cancer (like breast, lung, colon, or prostate cancer)
- You can speak and read in English or Spanish
- You are able to understand and agree to the study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new program to make it easier for Black and Latino people with cancer to join clinical trials. Your participation can help researchers learn how to improve access for everyone.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study tests new educational materials about genetic testing for cancer patients. It aims to find the best ways to explain genetic testing to people from different backgrounds, especially Black, Latino, and non-Latino non-Black communities.
This study tests an approach for discussing and sharing what patients value about their health, and adapting it for Latinx communities. It involves separate interviews with patients, families/caregivers, and oncology clinicians to improve how the intervention works and is understood.
This study uses a blood test to look for signs of lung cancer in people who have never smoked or smoked very little. It focuses on Asian and Latinx communities because certain gene changes are more common in these groups.
This study offers free genetic testing to cancer patients and their healthcare providers. It aims to help people who may not have easy access to genetic testing understand their cancer risk.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.